Stay updated on Ligelizumab in CSU Japanese Patients Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.

Latest updates to the Ligelizumab in CSU Japanese Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a metadata/versioning update and does not modify study content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated to v3.5.0 and the previous label v3.4.3 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedNew site revision (v3.4.2) and removal of an outdated funding/operating-status notice (v3.4.1) appear to be general site maintenance updates rather than changes to study content or critical functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a site-wide notice about government funding lapse and open status, directing users to cc.nih.gov and opm.gov. Updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check91 days agoChange DetectedCosmetic updates include adding a 'Show glossary' option, capitalization tweaks for QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), a new 'No FEAR Act Data' label, and revision tag 'v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Ligelizumab in CSU Japanese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Japanese Patients Clinical Trial page.